search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
11


giving them a long-term competitive advantage which is denied to UK companies, with many of them emulating UK schemes which have now been dismantled in the UK and which made UK companies successful.”


The way forward


GAMBICA supports UK Export Partners’ call for reform and will be pressing the government to focus on:


• Restoring seamless trade with the EU by renegotiating aspects of the UK-EU Trade Co-operation Agreement.


• Maintaining alignment with international standards and regulations, particularly those set by the EU, to keep UK goods competitive.


If you have thoughts on how grants for exporters should be administered, there’s still time to contribute. GAMBICA is inviting input for its response to the government consultation. Share your views by emailing jacqueline.balian@gambica.org.uk.


The stakes couldn’t be higher. It’s time for the UK to get serious about exports and give its businesses the tools they need to succeed on the global stage.


Good news from North Western Universities


Distributors within the GAMBICA membership have repeatedly voiced concerns about the imposition of a requirement for Professional Indemnity Insurance on those supplying universities with lab equipment. Just before Christmas, a group of GAMBICA members briefed the North Western Universities’ Purchasing Consortium on issues affecting the supply chain for lab equipment and this issue was raised again.


I’m pleased to be able to say that we have had a positive outcome! David Yates, Sustainable Relationships Manager for NWUPC has written to GAMBICA to say that as far as NWUPC is concerned PI insurance will only be requested where the relevant


agreement/contract would include the provision of advice upon which the customer is relying- typically linked to product design, particularly if the intellectual property of the customer is shared in supporting the design.


NWUPC advise that, where a supplier does not think PI is relevant to the advertised contract then they clarify this with the authority during the clarifi cation period.


Read, Share and Comment on this Article, visit: www.labmate-online.com


Solvent recycler drives sustainability in pharma labs


Biotech Fluidics has announced that a leading pharmaceutical company has invested in 17 SPR-200 solvent recycler units to enhance the sustainable use of solvents in HPLC systems across its analytical laboratories.


The SPR-200 operates as a standalone, externally powered unit, eliminating the need for an external computer and avoiding potential connectivity challenges with IT systems.


Designed for compatibility with most HPLC systems, the SPR- 200 continuously monitors detector output signals during liquid chromatography. In customer laboratories, it has demonstrated the ability to recover up to 90% of the mobile phase by redirecting purifi ed solvent into a dedicated reservoir during isocratic HPLC.


Fritiof Ponten, CEO of Biotech Fluidics, commented: “Controlled via an integral LED screen and membrane keyboard – the SPR- 200’s user-friendly software allows you to confi gure operational parameters and to perform online monitoring and create an audit trail of recovered solvent.”


He added: “Not only does the SPR-200 improve sustainability in your lab, but it also quickly pays for itself by enabling you to recycle nearly all the solvent used in your isocratic HPLC systems.”


More information online: ilmt.co/PL/1yBN 63687pr@reply-direct.com


Complex effl uent treatment plant installed at Pirbright Institute’s ISO11 building


Suncombe, a leading global supplier of hygienic process equipment and systems, played a leading role in the initial design, construction, implementation and commissioning of a new Effl uent Treatment Plant (ETP) for the ISO11 building at The Pirbright Institute in Surrey, UK. Pirbright is a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans.


The ISO11 building is used to conduct research into areas such as vaccine development, effi cacy testing and viral transmission biology. The project was initiated to replace the existing ETP, which was very old and with outdated controls. Due to the lack of available space, it was decided to design an externally-sited structure, made of specially manufactured shipping containers. The client needed to keep the building running with the old ETP, and then programme a much shorter change over.


A benefi t of building a containerised ETP was it allowed the equipment to be designed, manufactured, connected, installed and tested off-site and inclusion of all of the utilities and control systems in this single module. The Suncombe BioSuite Control Systems used have been specifi cally developed for ultimate control of these highly critical decontamination systems.


As a lot of the pipework was coming from inside the building, and controls cabling and interfaces were going back into the building coordination between the ETP construction and M&E contractors needed to be carefully managed.


Simulations of the various treatment cycles and stress testing of the complete system was undertaken. The plant was then installed on-site, and all the testing was then repeated in situ before handover.


Steve Overton, Suncombe Operations Director commented: “I am grateful to the Pirbright and 3PM personnel, as well as the Suncombe team, for delivering this complex and challenging project successfully.”


More information online: ilmt.co/PL/kw58 and ilmt.co/PL/bB39 63498pr@reply-direct.com


WWW.LABMATE-ONLINE.COM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36